Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer
Clinical trial NCT06504875 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06504875
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-10
- Primary completion
- 2025-07-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.